Agenus reported 17.82 in PE Price to Earnings for its fiscal quarter ending in June of 2022.





Pe Change Date
AbbVie 23.45 0.51 Sep/2026
Amgen 18.6 0.53 Sep/2026
AstraZeneca 24.63 0.71 Sep/2026
Bristol-Myers Squibb 10.44 5.7 Sep/2026
CSL 16.16 9.59 Dec/2025
Eli Lilly 64.5 31.61 Sep/2026
Gilead Sciences 17.68 4.18 Sep/2026
GlaxoSmithKline 9.72 0.9 Sep/2026
Glaxosmithkline 15.17 0.08 Sep/2026
Incyte 54.54 40.08 Sep/2026
Intrexon 7.54 221.44 Dec/2021
J&J 25.86 3.57 Sep/2026
Jiangsu Hengrui 38.75 11.58 Sep/2026
Merck 17.21 4.47 Jun/2026
Merck 34.36 2.11 Sep/2026
Northwest Biotherapeutics 11.67 6.93 Sep/2022
Novartis 19.17 3.24 Sep/2026
Novavax 2.01 1.07 Dec/2025
Pfizer 15.2 3.72 Sep/2026
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Veracyte 29.55 13.22 Sep/2026